Evidence map›Paper›PMID 42597469›Full record

Trial reportFrontiers in pediatrics2026

Impact of the Empower-DSD training program on the health-related quality of life in children, adolescents and young adults with differences of sex development and their parents.

Uta Neumann, Ralph Schilling, Sabine Wiegmann, Martina Ernst, Mirja Winter, Katja Wechsung, Louise Marshall, Ulla Döhnert, Olaf Hiort, Julia Rohayem and 8 more

Abstract readClinical Trial
In one paragraph

Trial report in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Uta NeumannClinic for Pediatric Endocrinology and Diabetology, Centre for Chronic Sick Children, ENDO-ERN-Centre, German Centre for Child and Adolescent Health (DZKJ)-Partner Site Berlin, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Ralph SchillingInstitute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Sabine WiegmannInstitute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Martina ErnstClinic for Pediatric Endocrinology and Diabetology, Centre for Chronic Sick Children, ENDO-ERN-Centre, German Centre for Child and Adolescent Health (DZKJ)-Partner Site Berlin, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Mirja WinterClinic for Pediatric Endocrinology and Diabetology, Centre for Chronic Sick Children, ENDO-ERN-Centre, German Centre for Child and Adolescent Health (DZKJ)-Partner Site Berlin, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Katja WechsungClinic for Pediatric Endocrinology and Diabetology, Centre for Chronic Sick Children, ENDO-ERN-Centre, German Centre for Child and Adolescent Health (DZKJ)-Partner Site Berlin, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Louise MarshallDivision of Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine, University of Luebeck, Luebeck, Germany.
Ulla DöhnertDivision of Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine, University of Luebeck, Luebeck, Germany.
Olaf HiortDivision of Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine, University of Luebeck, Luebeck, Germany.
Julia RohayemCentre for Reproductive Medicine and Andrology, Clinical and Operative Andrology, University Hospital Münster, Münster, Germany.
Klaus-Peter LiesenkötterCentre for Hormonal and Metabolic Disorders, Endokrinologikum Berlin, Berlin, Germany.
Annette Richter-UnruhMVZ Dr. Eberhard & Partner Dortmund, Dortmund, Germany.
Gerda Janssen-SchmidchenSHG Interfamilien, c/o Paritätischer Wohlfahrtsverband Niedersachsen e.V., Kreisverband Emden, Emden, Germany.
Gloria HerrmannCentre for Rare Endocrine Diseases (ZSEE), Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine, German Centre for Child and Adolescent Health (DZKJ)- Partner Site Ulm, Ulm University Medical Centre, Ulm, Germany.
Martin WabitschCentre for Rare Endocrine Diseases (ZSEE), Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine, German Centre for Child and Adolescent Health (DZKJ)- Partner Site Ulm, Ulm University Medical Centre, Ulm, Germany.
Stephanie RollInstitute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Thomas KeilInstitute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Barbara StöckigtInstitute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Treatment of individuals with a difference of sex development (DSD) must respect ethical principles, human rights, and national laws. Informed consent is central and should be supported by age-appropriate information from early on. In Germany, genital surgery in DSD is prohibited until autonomous consent is possible, requiring sufficient maturity and proper information. DSD may negatively affect individuals and their families' health-related quality of life (HRQoL) and may be associated with stigmatization, inadequate information and lack of peer counseling. We examined if HRQoL of affected individuals and their parents can be improved by a newly developed multidisciplinary training program. Methods: In collaboration with self-help organisations, the Empower-DSD consortium developed and implemented a two-day modular educational program for children and young adults (6-24 years) with DSD (Congenital adrenal hyperplasia, Turner-syndrome, Klinefelter-syndrome, other 46,XX and 46,XY-DSD diagnoses) and their families, addressing diagnosis-specific and psychosocial topics. From 08/2020 to 09/2022, 104 multidisciplinary sessions were conducted in five German DSD centres. As primary endpoint, participants completed HRQoL questionnaires (WHO-5, KINDL) at baseline, and three and six months post-program. Data were analyzed separately for children (6-13), adolescents (14-17), young adults (18-24), and parents. Additionally, qualitative interviews and participatory observations of children's sessions were analyzed using qualitative content analysis within a mixed methods approach. Results: We evaluated 102 children, 95 adolescents, 56 young adults, and 380 parents/relatives. Questionnaire completion rates were 96% at baseline and 60% at 6 months. HRQoL was stable or improved in over 66% of children and parents, and in 57% of adolescents and young adults at 6 months. Qualitative analysis of 71 interviews and four observed sessions indicated participants felt empowered by the psychological support and the exchange with peers and valued the opportunity to discuss their diagnosis openly. Conclusion: Children with DSD and their parents seemed to benefit more from the new education program than adolescents and young adults with DSD. Overall, the two-day program encourages engagement with DSD diagnosis. The exchange with other people with DSD or parents was experienced as empowerment. Further research should include long-term follow-ups to determine the sustainable effects of multidisciplinary training programs. Clinical Trial Registration: https://innovationsfonds.g-ba.de/projekte/empower-dsd.219, identifier DRKS00023096.

Indexed as

acquire diagnosis-specific knowledgeadolescentschildrendifferences of sex development (DSD)health related quality of life (HRQoL)multidisciplinary training programme

Identifiers

PMID42597469
PMCPMC13468784

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.